JOÃO EDUARDO NUNES SALLES
Check the activity agenda
Thursday, June 27, 2024
• Room 6 - Rafael Gomez-Cuevas
16:30-17:30
THE IMPACT OF OBESITY TREATMENT BEYOND WEIGHT LOSS
Speaker: João Eduardo Nunes Salles (SP)
Friday, June 28, 2024
• Room 2 - John Waterlow
16:30-18:00
SESSION: OBESITY IN THE ELDERLY: IMPACT ON MUCLES AND BONES
Abstracts - 128677: HIGH-INTENSITY INTERVAL TRAINING IMPROVES CARDIOMYOCYTE CONTRACTILE FUNCTION AND INTRACELLULAR CALCIUM HANDLING IN OBESE RATS - Presenter: André Soares Leopoldo
Sarcopenic obesity: emerging mechanisms and diagnosis
Obesity and skeletal fragility
Skeletal muscle and metabolic health: how do we increase muscle mass and function in people with obesity and type 2 Diabetes?
Discussion
Coordinator: Fábio Rogerio Trujilho (BA)
Coordinator: Adela González Barnech (Uruguay)
Abstracts - 128677: HIGH-INTENSITY INTERVAL TRAINING IMPROVES CARDIOMYOCYTE CONTRACTILE FUNCTION AND INTRACELLULAR CALCIUM HANDLING IN OBESE RATS - Presenter: André Soares Leopoldo
Sarcopenic obesity: emerging mechanisms and diagnosis
Speaker: João Eduardo Nunes Salles (SP)
Obesity and skeletal fragility
Speaker: Francisco José A. de Paula (SP)
Skeletal muscle and metabolic health: how do we increase muscle mass and function in people with obesity and type 2 Diabetes?
Speaker: Bruno Gualano (SP)
Discussion
• Room 4 - Peter Kopelman
08:00-09:30
SYMPOSIUM: SBD-ABESO - OBESITY AND TYPE 2 DIABETES
Obesity and weight management for prevention of T2DM
MASH in diabetes: should we be worried about liver or cardiovascular outcomes?
Remission of diabetes with clinical weight loss: a viable approach?
Metabolic surgery in T2D: unraveling the role of WL in T2D improvement and remission
Discussion
Coordinator: Maria Edna de Melo (SP)
Coordinator: Jacqueline Rizzolli (RS)
Obesity and weight management for prevention of T2DM
Speaker: João Eduardo Nunes Salles (SP)
MASH in diabetes: should we be worried about liver or cardiovascular outcomes?
Speaker: Rodrigo Nunes Lamounier (MG)
Remission of diabetes with clinical weight loss: a viable approach?
Speaker: Fernando Valente (SP)
Metabolic surgery in T2D: unraveling the role of WL in T2D improvement and remission
Speaker: Marcio C. Mancini (SP)
Discussion
• Room 6 - Rafael Gomez-Cuevas
14:00-15:30
SESSION: ABSTRACTS - CLINICAL 2
Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves metabolic risk factors in adults living with obesity: analysis of a placebo-controlled, randomised phase 2 trial
129848 - ASSESSMENT OF THE PERFORMANCE OF BODY ADIPOSITY INDEXES, RELATIVE FAT MASS AND BODY ROUNDNESS IN THE ASSESSMENT OF BODY ADIPOSITY AND INSULIN RESISTANCE IN ADULTS
128863 - ADOLESCENTS WITH HIGHER CALORIC INTAKE AT LATER HOURS ARE MORE LIKELY TO HAVE AN INCREASED RISK OF EXCESS WEIGHT: RESULTS FROM A POPULATION-BASED STUDY
129851 - GRAZING AFTER BARIATRIC SURGERY: PSYCHIATRIC COMORBIDITY AND WEIGHT OUTCOMES
128961 - OPTIMIZATION OF PATIENT ENGAGEMENT IN THE PHASE 3 CLINICAL TRIAL PROGRAM FOR SURVODUTIDE IN OBESITY THROUGH SIMULATION
128571 - METABOLIC PROFILE AND ITS RISKS IN A NON-DIABETIC POPULATION UNDERGOING KIDNEY TRANSPLANT
128581 - THE ANTIVIRAL IMMUNE DEFENSE MAY BE ADVERSELY INFLUENCED BY WEIGHT LOSS THROUGH A CALORIE RESTRICTION PROGRAM IN OBESE WOMEN
Judge: Cintia Cercato (SP)
Judge: João Eduardo Nunes Salles (SP)
Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves metabolic risk factors in adults living with obesity: analysis of a placebo-controlled, randomised phase 2 trial
129848 - ASSESSMENT OF THE PERFORMANCE OF BODY ADIPOSITY INDEXES, RELATIVE FAT MASS AND BODY ROUNDNESS IN THE ASSESSMENT OF BODY ADIPOSITY AND INSULIN RESISTANCE IN ADULTS
128863 - ADOLESCENTS WITH HIGHER CALORIC INTAKE AT LATER HOURS ARE MORE LIKELY TO HAVE AN INCREASED RISK OF EXCESS WEIGHT: RESULTS FROM A POPULATION-BASED STUDY
129851 - GRAZING AFTER BARIATRIC SURGERY: PSYCHIATRIC COMORBIDITY AND WEIGHT OUTCOMES
128961 - OPTIMIZATION OF PATIENT ENGAGEMENT IN THE PHASE 3 CLINICAL TRIAL PROGRAM FOR SURVODUTIDE IN OBESITY THROUGH SIMULATION
128571 - METABOLIC PROFILE AND ITS RISKS IN A NON-DIABETIC POPULATION UNDERGOING KIDNEY TRANSPLANT
128581 - THE ANTIVIRAL IMMUNE DEFENSE MAY BE ADVERSELY INFLUENCED BY WEIGHT LOSS THROUGH A CALORIE RESTRICTION PROGRAM IN OBESE WOMEN
Saturday, June 29, 2024
• Room 3 - Bernard Jeanrenaud
08:00-09:30
SESSION: OBESITY AND TYPE 2 DIABETES
Role of the lymphatic system in visceral obesity and the metabolic syndrome
Effects of obesity on beta-cells
Weight dependent effects on diabetic kidney disease
Discussion
Coordinator: João Eduardo Nunes Salles (SP)
Role of the lymphatic system in visceral obesity and the metabolic syndrome
Speaker: Vincenza Cifarelli (United States)
Effects of obesity on beta-cells
Speaker: Franco Folli (Italy)
Weight dependent effects on diabetic kidney disease
Speaker: Cristiane Bauermann Leitão (RS)
Discussion
Venue
Centro de Convenções Frei Caneca
R. Frei Caneca, 569 - Bela Vista,
São Paulo - SP, 01307-001
R. Frei Caneca, 569 - Bela Vista,
São Paulo - SP, 01307-001
website ACCOMMODATION
PROMOTED BY
MANAGEMENT
Tourism Agency
DIAMOND SPONSOR
GOLD SPONSOR
BRONZE SPONSOR
SPONSOR
